Market Tracker

05/06 6:45pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

2.66
Delayed Data
As of 3:59pm ET
 -0.15 / -5.34%
Today’s Change
2.10
Today|||52-Week Range
8.75
-13.92%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close2.81
Today’s open2.79
Day’s range2.65 - 2.79
Volume35,124
Average volume (3 months)74,241
Market cap$73.6M
Dividend yield--
Data as of 3:59pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+12.17%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book1.88

Competitors

 Today’s
change
Today’s
% change
CHMAChiasma Inc-0.08-2.64%
LIFEaTyr Pharma Inc-0.12-3.73%
APDNApplied DNA Sciences...+0.04+1.37%
CEMIChembio Diagnostics ...+0.03+0.41%
Data as of 4:00pm ET, 05/06/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer, Treasurer &
Senior VP
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts